HELX - Franklin Genomic Advancements ETF
Stock Price: $45.08 USD
-0.52 (-1.15%)
Updated Apr 16, 2021 4:00 PM EDT - Market closed
After-hours: $45.08 0.00 (0.00%) Apr 16, 8:00 PM
| Assets | $4.56M |
| NAV | $45.59 |
| Expense Ratio | 0.50% |
| PE Ratio | n/a |
| Beta (5Y) | -2.37 |
| Dividend (ttm) | $0.05 |
| Dividend Yield | 0.11% |
| Ex-Dividend Date | Dec 14, 2020 |
| 1-Year Return | - |
| Trading Day | April 16 |
| Last Price | $45.08 |
| Previous Close | $45.60 |
| Change ($) | -0.52 |
| Change (%) | -1.15% |
| Day's Open | 45.89 |
| Day's Range | 45.04 - 45.89 |
| Day's Volume | 433 |
| 52-Week Range | 25.09 - 53.47 |
Fund Description
The investment seeks capital appreciation. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.
| Asset Class Equity | Inception Date Feb 25, 2020 |
| Exchange BATS | Ticker Symbol HELX |
| Index Tracked Solactive Genomics Index | |
News
There are no news available yet.